Mangalore Capital Expenditures from 2010 to 2025

MANGCHEFER   145.29  3.76  2.66%   
Mangalore Chemicals' Capital Expenditures is increasing over the years with slightly volatile fluctuation. Capital Expenditures is expected to dwindle to about 925 M. During the period from 2010 to 2025 Mangalore Chemicals Capital Expenditures annual values regression line had geometric mean of  741,344,003 and mean square error of 498914.7 T. View All Fundamentals
 
Capital Expenditures  
First Reported
2006-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
510.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mangalore Chemicals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mangalore Chemicals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 864.3 M, Interest Expense of 655.1 M or Total Revenue of 29.9 B, as well as many indicators such as . Mangalore financial statements analysis is a perfect complement when working with Mangalore Chemicals Valuation or Volatility modules.
  
This module can also supplement various Mangalore Chemicals Technical models . Check out the analysis of Mangalore Chemicals Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Mangalore Stock

Mangalore Chemicals financial ratios help investors to determine whether Mangalore Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalore with respect to the benefits of owning Mangalore Chemicals security.